Optos
Dunfermline
About Optos
Optos plc has the vision to be The retina company. We aim to be recognised as a leading provider of devices and solutions to eyecare professionals for improved patient care. Optos' core devices produce ultra widefield, high resolution digital images (optomaps) of approximately 82% of the retina, something no other device is capable of doing in any one image. Optos has a range of imaging devices that support different customer segments and patient levels: the P200 and 200Dx devices are concentrated on wellness screening carried out by optometrists and ophthalmologists in primary care; the P200C devices are designed to meet the need for more exacting clinical imaging capabilities and standards in secondary care within the ophthalmology market and at optometric practices that are clinically managing a patient base with advanced ocular disease; and the P200MA and 200Tx devices supports ophthalmologists and retinal specialists in the medical care market.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Funding stage: M&A
- Last round: Grant (Sep 2020)
- Ticker: lse:OPTS
- Website: optos.com
- Phone: 1(383) 843-300
Industries & Categories
Health Care, Medical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/optos-3380015 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.